GlassScriptPhysician profile
Syed Akbar
NPI 1780979955
$18,510.23
in general payments reported to CMS, 2019-2025
61 companies · $5,128 in 2025
The $5,128 reported for 2025 was more than what 82% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $240 · 2021: $321 · 2022: $3,669 · 2023: $3,096 · 2024: $5,921 · 2025: $5,128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,855 · Consulting Fee: $6,200 · Education: $90.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,855.29 |
| Consulting Fee | $6,200.00 |
| Education | $90.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $6,002.74 | 2020-2025 | Imfinzi, Lynparza, Enhertu |
| Daiichi Sankyo INC. | $3,164.17 | 2023-2025 | Enhertu, Injectafer, Datroway |
| Seagen INC. | $1,353.39 | 2022-2023 | Tukysa, Adcetris |
| Incyte Corporation | $1,017.31 | 2022-2025 | Jakafi, Pemazyre, Monjuvi |
| Novartis Pharmaceuticals Corporation | $610.06 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $514.79 | 2023-2025 | Keytruda, Welireg, Keytruda Qlex |
| Janssen Biotech, INC. | $508.30 | 2022-2025 | Rybrevant, Darzalex, Erleada |
| Regeneron Healthcare Solutions, INC. | $462.83 | 2024-2025 | Libtayo |
| Pfizer INC. | $419.82 | 2022-2025 | |
| Eisai INC. | $248.75 | 2023-2025 | |
| Beone Medicines USA, INC. | $241.79 | 2025 | Brukinsa, Tevimbra |
| E.R. Squibb & Sons, L.L.C. | $239.98 | 2019-2024 | Opdivo |
| Springworks Therapeutics, INC. | $213.72 | 2024-2025 | Ogsiveo |
| Genzyme Corporation | $211.68 | 2022-2025 | |
| Genentech USA, INC. | $201.44 | 2023-2025 | Polivy, Tecentriq, Alecensa |
Show all 61 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $189.72 | 2024-2025 | |
| Glaxosmithkline, LLC. | $177.35 | 2023-2025 | Jemperli, Ojjaara, Zejula |
| Janssen Pharmaceuticals, INC | $150.07 | 2023 | Xarelto |
| Tempus Ai, INC | $137.77 | 2024-2025 | Xt Cdx |
| Lilly USA, LLC | $133.62 | 2022-2025 | Verzenio, Retevmo, Jaypirca |
| Array Biopharma INC | $124.91 | 2024-2025 | Mektovi, Braftovi, Lorbrena |
| Aveo Pharmaceuticals, INC. | $124.84 | 2023-2025 | Fotivda |
| Celgene Corporation | $120.92 | 2022-2025 | Reblozyl, Opdivo |
| Emd Serono, INC. | $113.36 | 2023-2025 | Tepmetko |
| Abbvie INC. | $98.54 | 2023-2025 | Venclexta |
| Stemline Therapeutics INC. | $97.82 | 2023-2025 | Orserdu |
| Coherus Oncology, INC. | $95.74 | 2025 | Loqtorzi |
| Adc Therapeutics America, INC. | $93.88 | 2023-2025 | |
| Alexion Pharmaceuticals, INC. | $88.02 | 2023-2024 | Ultomiris |
| Bayer Healthcare Pharmaceuticals INC. | $83.59 | 2023-2024 | |
| Exelixis INC. | $79.76 | 2019-2023 | Cabometyx |
| Mirati Therapeutics, INC. | $74.09 | 2023-2024 | Krazati |
| Merit Medical Systems INC | $71.35 | 2025 | Elation Balloon Dilator, Aeromini Stent and Delivery System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.39 | 2025 | Jardiance |
| Astellas Pharma US INC | $65.24 | 2022-2025 | Vyloy |
| Karyopharm Therapeutics INC. | $62.99 | 2023-2024 | Xpovio |
| Geron Corporation | $60.30 | 2025 | Rytelo |
| Takeda Pharmaceuticals U.S.A., INC. | $59.71 | 2024-2025 | Alunbrig, Ninlaro |
| Deciphera Pharmaceuticals INC. | $54.04 | 2025 | Qinlock, Romvimza |
| Rigel Pharmaceuticals, INC. | $53.27 | 2023-2024 | Rezlidhia, Tavalisse |
| Tersera Therapeutics LLC | $49.95 | 2023-2024 | Zoladex |
| Sobi, INC | $48.90 | 2024-2025 | |
| Puma Biotechnology, INC. | $44.95 | 2024-2025 | |
| Ipsen Biopharmaceuticals, INC | $43.19 | 2022-2024 | Onivyde |
| Blueprint Medicines Corporation | $42.22 | 2023 | Ayvakit |
| Agios Pharmaceuticals, INC. | $38.98 | 2024-2025 | Pyrukynd |
| Chiesi USA, INC. | $38.00 | 2023 | Ferriprox |
| Kite Pharma, INC. | $35.46 | 2022-2025 | Yescarta |
| Fennec Pharmaceuticals, INC. | $33.80 | 2024 | Pedmark |
| Beigene USA, INC. | $31.17 | 2024 | Brukinsa |
| Kyowa Kirin, INC. | $27.14 | 2024 | Poteligeo |
| Jazz Pharmaceuticals INC. | $26.35 | 2025 | |
| Taiho Oncology, INC. | $23.32 | 2023 | |
| Acrotech Biopharma INC. | $22.61 | 2025 | Beleodaq |
| Immunocore Limited | $21.07 | 2025 | Kimmtrak |
| Adaptive Biotechnologies Corporation | $19.48 | 2025 | Clonoseq |
| Amgen INC. | $17.52 | 2023 | Kyprolis |
| Emmaus Medical, INC. | $16.98 | 2023 | Endari |
| Legend Biotech USA INC. | $13.65 | 2025 | Carvykti |
| Progenics Pharmaceuticals, INC. | $13.39 | 2022 | |
| Iovance Biotherapeutics, INC. | $10.04 | 2025 | Amtagvi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Akbar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.